Leptin Analog [EPC]

Leptin Analog [EPC] was reported 1263 times

Drugs of the Leptin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LEPTIN LEVEL DECREASED 3 0.7500
1 LEPTIN LEVEL INCREASED 3 0.2727
2 RENAL MALPOSITION 1 0.0909
3 ANODONTIA 1 0.0769
4 LABORATORY TEST NORMAL 1 0.0667
5 GENITALS ENLARGED 1 0.0556
6 NASAL MUCOSAL HYPERTROPHY 1 0.0500
7 GLUCOSE TOLERANCE DECREASED 2 0.0488
8 DIET NONCOMPLIANCE 17 0.0462
9 NEUTRALISING ANTIBODIES POSITIVE 19 0.0456
10 CONGENITAL URINARY TRACT OBSTRUCTION 1 0.0455
11 MUCOSAL PROLAPSE SYNDROME 1 0.0370
12 PLICA SYNDROME 1 0.0370
13 ALPHA TUMOUR NECROSIS FACTOR INCREASED 3 0.0323
14 BILATERAL BREAST BUDS 1 0.0294
15 PSYCHOMOTOR DISADAPTATION SYNDROME 1 0.0244
16 NEUTRALISING ANTIBODIES 3 0.0238
17 MEDICAL DEVICE SITE HAEMATOMA 1 0.0217
18 BLOOD PRESSURE AMBULATORY INCREASED 1 0.0217
19 RED BLOOD CELL SPHEROCYTES PRESENT 1 0.0175
20 FOCAL PERITONITIS 1 0.0161
21 CONGENITAL JOINT MALFORMATION 1 0.0159
22 INSULIN RESISTANCE 33 0.0158
23 FAT TISSUE DECREASED 6 0.0154
24 INTRADUCTAL PAPILLARY-MUCINOUS CARCINOMA OF PANCREAS 1 0.0154
25 XANTHOMA 3 0.0149
26 MITOCHONDRIAL ENCEPHALOMYOPATHY 1 0.0141
27 HAMARTOMA 1 0.0132
28 PRIMARY IMMUNODEFICIENCY SYNDROME 1 0.0123
29 FATTY ACID DEFICIENCY 1 0.0122
30 POST INFECTION GLOMERULONEPHRITIS 1 0.0119
31 BLOOD TRIGLYCERIDES DECREASED 4 0.0119
32 GENDER DYSPHORIA 1 0.0114
33 ACANTHOSIS NIGRICANS 2 0.0108
34 GASTRIC ULCER HELICOBACTER 1 0.0105
35 BLOOD VISCOSITY ABNORMAL 1 0.0105
36 DERMATOFIBROSARCOMA PROTUBERANS 1 0.0104
37 PHARYNGEAL STENOSIS 1 0.0097
38 MALABSORPTION FROM INJECTION SITE 3 0.0097
39 ZINC DEFICIENCY 2 0.0093
40 LUPUS VASCULITIS 1 0.0093
41 REFRACTORINESS TO PLATELET TRANSFUSION 1 0.0092
42 SUPERIOR MESENTERIC ARTERY SYNDROME 2 0.0090
43 PRODUCT USED FOR UNKNOWN INDICATION 11 0.0087
44 BODY HEIGHT ABNORMAL 1 0.0086
45 PANCREATITIS RELAPSING 7 0.0086
46 INCREASED INSULIN REQUIREMENT 2 0.0084
47 ABDOMINAL WALL MASS 1 0.0082
48 LEMIERRE SYNDROME 1 0.0080
49 BLOOD TRIGLYCERIDES ABNORMAL 7 0.0080
50 PAPILLARY RENAL CELL CARCINOMA 1 0.0074
51 CARCINOID TUMOUR OF THE STOMACH 1 0.0071
52 OVARIAN GERM CELL TERATOMA BENIGN 1 0.0071
53 SILENT THYROIDITIS 1 0.0069
54 HYPERTRIGLYCERIDAEMIA 38 0.0065
55 ADNEXAL TORSION 2 0.0063
56 PROSOPAGNOSIA 1 0.0063
57 ADNEXA UTERI CYST 1 0.0062
58 ENDOMETRIAL CANCER METASTATIC 1 0.0062
59 INFLAMMATION OF WOUND 2 0.0060
60 HYPERPHAGIA 23 0.0058
61 STEATOHEPATITIS 3 0.0056
62 BLOOD INSULIN ABNORMAL 1 0.0053
63 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
64 BIOPSY LIVER 2 0.0049
65 DESMOID TUMOUR 1 0.0048
66 MITOCHONDRIAL CYTOPATHY 2 0.0045
67 LIPASE ABNORMAL 1 0.0045
68 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 1 0.0039
69 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
70 CONJUNCTIVITIS VIRAL 1 0.0038
71 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 1 0.0037
72 GROWTH DISORDER 1 0.0037
73 PRODUCT CLOSURE ISSUE 2 0.0036
74 DIABETIC GANGRENE 1 0.0035
75 PAPILLARY THYROID CANCER 6 0.0034
76 POST PROCEDURAL PNEUMONIA 1 0.0033
77 PROCTOCOLECTOMY 1 0.0033
78 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
79 HYPERINSULINAEMIA 1 0.0033
80 PAPILLOMA 1 0.0032
81 PSEUDOCYST 1 0.0031
82 ANOREXIA NERVOSA 1 0.0031
83 BLOOD TRIGLYCERIDES INCREASED 54 0.0031
84 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
85 LIPIDS ABNORMAL 2 0.0028
86 FAT TISSUE INCREASED 4 0.0028
87 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
88 OTITIS MEDIA ACUTE 2 0.0027
89 PRODUCT SUPPLY ISSUE 19 0.0027
90 ADENOIDAL HYPERTROPHY 1 0.0026
91 PREGNANCY TEST POSITIVE 1 0.0025
92 KETONURIA 2 0.0025
93 LAGOPHTHALMOS 1 0.0024
94 INTESTINAL PROLAPSE 1 0.0024
95 OROPHARYNGEAL SPASM 1 0.0024
96 ENDOCRINE DISORDER 3 0.0023
97 HEPATIC ATROPHY 1 0.0022
98 MUSCLE MASS 1 0.0022
99 DIABETIC METABOLIC DECOMPENSATION 3 0.0022
100 EATING DISORDER SYMPTOM 1 0.0022
101 ADRENAL NEOPLASM 1 0.0021
102 GASTRIC VARICES 1 0.0021
103 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
104 ARTERIOVENOUS FISTULA 1 0.0020
105 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
106 AORTIC VALVE CALCIFICATION 1 0.0019
107 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
108 ORTHOPAEDIC PROCEDURE 1 0.0019
109 GLYCOSYLATED HAEMOGLOBIN DECREASED 3 0.0019
110 OSTEOMYELITIS ACUTE 1 0.0018
111 BLADDER DILATATION 2 0.0018
112 GROIN INFECTION 1 0.0018
113 MACROGLOSSIA 1 0.0018
114 BLOOD INSULIN INCREASED 1 0.0018
115 OESOPHAGEAL FOOD IMPACTION 1 0.0018
116 THERAPY CESSATION 92 0.0018
117 MEDICAL DEVICE SITE PAIN 1 0.0018
118 INJECTION SITE SCAR 5 0.0018
119 EYE ULCER 1 0.0017
120 LARYNGEAL STENOSIS 1 0.0017
121 LACRIMAL DISORDER 1 0.0017
122 DRUG SPECIFIC ANTIBODY PRESENT 11 0.0017
123 ADRENAL ADENOMA 1 0.0017
124 PRODUCT PREPARATION ISSUE 11 0.0017
125 GINGIVAL HYPERPLASIA 1 0.0017
126 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
127 POSTOPERATIVE THROMBOSIS 1 0.0017
128 FAT NECROSIS 1 0.0016
129 GLYCOSYLATED HAEMOGLOBIN INCREASED 41 0.0016
130 HELICOBACTER GASTRITIS 2 0.0016
131 LIPOHYPERTROPHY 1 0.0016
132 NON-CARDIAC CHEST PAIN 5 0.0016
133 ANION GAP 1 0.0016
134 PANCREATIC CYST 3 0.0016
135 ADENOCARCINOMA PANCREAS 2 0.0016
136 GLIOMA 1 0.0016
137 MITRAL VALVE CALCIFICATION 1 0.0016
138 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
139 LIPIDS INCREASED 3 0.0015
140 CYST RUPTURE 1 0.0015
141 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
142 LIPODYSTROPHY ACQUIRED 3 0.0014
143 DIABETIC ULCER 1 0.0014
144 CERVICAL RADICULOPATHY 1 0.0014
145 HEPATIC STEATOSIS 26 0.0014
146 ANTIBODY TEST ABNORMAL 1 0.0014
147 GASTROINTESTINAL SCARRING 1 0.0014
148 METABOLIC DISORDER 8 0.0014
149 BACTERIAL DISEASE CARRIER 1 0.0014
150 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
151 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
152 GINGIVAL ABSCESS 1 0.0013
153 CHLAMYDIAL INFECTION 1 0.0013
154 MICROALBUMINURIA 1 0.0013
155 DIABETIC FOOT 4 0.0013
156 AUTOIMMUNE HEPATITIS 9 0.0013
157 POLYCYSTIC OVARIES 2 0.0013
158 BLOOD KETONE BODY INCREASED 1 0.0013
159 EXTRADURAL ABSCESS 1 0.0013
160 CROUP INFECTIOUS 1 0.0013
161 AORTIC DISORDER 1 0.0013
162 PANCREATITIS CHRONIC 3 0.0013
163 PNEUMONIA MYCOPLASMAL 1 0.0013
164 WEIGHT ABNORMAL 3 0.0012
165 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
166 DIABETES MELLITUS INADEQUATE CONTROL 22 0.0012
167 BALANOPOSTHITIS 1 0.0012
168 GASTRIC DILATATION 2 0.0012
169 TONSILLAR HYPERTROPHY 2 0.0012
170 ACUTE SINUSITIS 2 0.0012
171 THYROIDECTOMY 2 0.0012
172 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
173 ANIMAL BITE 3 0.0011
174 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
175 HYPERPLASIA 1 0.0011
176 ANAEMIA OF CHRONIC DISEASE 1 0.0011
177 PROTEIN URINE 1 0.0011
178 INJECTION SITE DRYNESS 1 0.0011
179 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
180 BLOOD PHOSPHORUS INCREASED 3 0.0011
181 CERUMEN IMPACTION 1 0.0011
182 HYPERTRICHOSIS 2 0.0011
183 PSYCHOGENIC SEIZURE 1 0.0011
184 BONE CYST 1 0.0011
185 OVARIAN DISORDER 1 0.0011
186 INFECTED SKIN ULCER 2 0.0011
187 BRAIN STEM HAEMORRHAGE 1 0.0011
188 LIPOATROPHY 1 0.0011
189 MENOMETRORRHAGIA 2 0.0010
190 SKIN TEXTURE ABNORMAL 1 0.0010
191 INJECTION SITE SCAB 1 0.0010
192 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
193 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
194 ATROPHY 2 0.0010
195 HORMONE LEVEL ABNORMAL 5 0.0010
196 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
197 HEPATOMEGALY 10 0.0010
198 UNDERWEIGHT 2 0.0010
199 TYPE 1 DIABETES MELLITUS 6 0.0010
200 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
201 BLOOD GLUCOSE ABNORMAL 18 0.0010
202 BREAST NEOPLASM 1 0.0010
203 TREATMENT NONCOMPLIANCE 53 0.0010
204 RESPIRATORY TRACT IRRITATION 1 0.0010
205 PANCREATITIS ACUTE 21 0.0009
206 STRESS URINARY INCONTINENCE 1 0.0009
207 GALLBLADDER ENLARGEMENT 1 0.0009
208 BINGE EATING 1 0.0009
209 THERAPY INTERRUPTED 66 0.0009
210 KETOSIS 1 0.0009
211 KIDNEY ENLARGEMENT 1 0.0009
212 CRYPTORCHISM 1 0.0009
213 STRESS AT WORK 1 0.0009
214 HALO VISION 1 0.0009
215 LUMBAR RADICULOPATHY 1 0.0009
216 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
217 LIVE BIRTH 7 0.0008
218 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
219 INJECTION SITE VESICLES 5 0.0008
220 HYPOGLYCAEMIA 40 0.0008
221 GLOMERULONEPHRITIS 2 0.0008
222 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
223 POST-ACUTE COVID-19 SYNDROME 1 0.0008
224 INJECTION SITE INFLAMMATION 4 0.0008
225 FRACTURED COCCYX 1 0.0008
226 GLUCOSE URINE PRESENT 1 0.0008
227 OVARIAN CYST RUPTURED 1 0.0008
228 HEPATOSPLENOMEGALY 2 0.0008
229 LIBIDO DISORDER 1 0.0008
230 HYPERGLYCAEMIA 28 0.0008
231 IRON DEFICIENCY ANAEMIA 7 0.0008
232 ACROCHORDON 1 0.0008
233 ANAL ABSCESS 4 0.0007
234 BODY MASS INDEX INCREASED 1 0.0007
235 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
236 DRUG SPECIFIC ANTIBODY 1 0.0007
237 CORNEAL ABRASION 1 0.0007
238 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
239 DISCHARGE 1 0.0007
240 DEATH NEONATAL 1 0.0007
241 HUNGER 10 0.0007
242 BLOOD GLUCOSE DECREASED 33 0.0007
243 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
244 MAJOR DEPRESSION 5 0.0007
245 ACUTE ABDOMEN 1 0.0007
246 INCREASED APPETITE 13 0.0007
247 GROWTH RETARDATION 2 0.0007
248 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
249 RHINITIS ALLERGIC 3 0.0007
250 CHOLANGIOCARCINOMA 1 0.0007
251 ANGIOPLASTY 1 0.0007
252 METABOLIC ENCEPHALOPATHY 2 0.0007
253 INFERTILITY 1 0.0007
254 INTELLECTUAL DISABILITY 1 0.0007
255 FUNGAL PERITONITIS 1 0.0007
256 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
257 MASTICATION DISORDER 2 0.0007
258 PORTAL HYPERTENSION 2 0.0006
259 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
260 MYELITIS 1 0.0006
261 PANCREATITIS 34 0.0006
262 HEPATIC ENCEPHALOPATHY 6 0.0006
263 UMBILICAL HERNIA 3 0.0006
264 BACTERIAL VAGINOSIS 1 0.0006
265 VAGINAL INFECTION 3 0.0006
266 DIABETIC KETOACIDOSIS 15 0.0006
267 RESPIRATORY ALKALOSIS 1 0.0006
268 METABOLIC SYNDROME 1 0.0006
269 PANCREATIC DISORDER 3 0.0006
270 SEBORRHOEIC DERMATITIS 1 0.0006
271 IGA NEPHROPATHY 1 0.0006
272 ANTIBODY TEST POSITIVE 1 0.0006
273 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
274 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
275 SPLEEN DISORDER 1 0.0006
276 EXPOSURE TO SARS-COV-2 1 0.0006
277 HEPATIC FIBROSIS 2 0.0006
278 INJECTION SITE OEDEMA 1 0.0006
279 LEFT VENTRICULAR FAILURE 2 0.0006
280 CERVICAL SPINAL STENOSIS 1 0.0006
281 SERUM FERRITIN DECREASED 1 0.0006
282 WEIGHT FLUCTUATION 6 0.0006
283 SPLENIC INFARCTION 1 0.0006
284 AORTIC VALVE STENOSIS 1 0.0006
285 PRODUCT TAMPERING 1 0.0006
286 NEEDLE ISSUE 16 0.0005
287 BLOOD GLUCOSE FLUCTUATION 6 0.0005
288 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
289 UROSEPSIS 5 0.0005
290 MATERNAL EXPOSURE DURING PREGNANCY 48 0.0005
291 DYSENTERY 1 0.0005
292 BLOOD CHOLESTEROL DECREASED 1 0.0005
293 BLADDER SPASM 1 0.0005
294 BLOOD BICARBONATE DECREASED 1 0.0005
295 PRODUCT STORAGE ISSUE 2 0.0005
296 GUN SHOT WOUND 1 0.0005
297 GINGIVAL RECESSION 1 0.0005
298 VITAMIN D DEFICIENCY 5 0.0005
299 PYELONEPHRITIS ACUTE 1 0.0005
300 EMPYEMA 1 0.0005
301 ARTHRITIS BACTERIAL 2 0.0005
302 DIABETES MELLITUS 37 0.0005
303 LEG AMPUTATION 2 0.0005
304 POLYCYTHAEMIA 1 0.0005
305 ATRIAL THROMBOSIS 1 0.0005
306 MICROCYTIC ANAEMIA 1 0.0005
307 HEPATIC CIRRHOSIS 9 0.0005
308 LIVEDO RETICULARIS 1 0.0005
309 ILL-DEFINED DISORDER 29 0.0005
310 EYE CONTUSION 1 0.0005
311 BUNDLE BRANCH BLOCK LEFT 2 0.0005
312 RENAL NEOPLASM 1 0.0005
313 AORTIC VALVE INCOMPETENCE 2 0.0005
314 ANAEMIA MACROCYTIC 1 0.0005
315 PRODUCT CONTAINER ISSUE 4 0.0005
316 LIVER FUNCTION TEST INCREASED 10 0.0005
317 INFUSION SITE BRUISING 1 0.0005
318 PERIODONTITIS 1 0.0005
319 OLIGOMENORRHOEA 1 0.0005
320 ENDOMETRIAL CANCER 1 0.0005
321 NOSOCOMIAL INFECTION 1 0.0005
322 INFECTIOUS MONONUCLEOSIS 1 0.0004
323 BLOOD GLUCOSE INCREASED 84 0.0004
324 IRON DEFICIENCY 2 0.0004
325 DEVELOPMENTAL DELAY 4 0.0004
326 CHRONIC GASTRITIS 1 0.0004
327 OSTEOMYELITIS 8 0.0004
328 DISEASE COMPLICATION 2 0.0004
329 ORAL PRURITUS 1 0.0004
330 HAIR GROWTH ABNORMAL 3 0.0004
331 INFUSION SITE INFECTION 1 0.0004
332 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
333 APPENDICITIS 4 0.0004
334 DISCOURAGEMENT 1 0.0004
335 PRE-ECLAMPSIA 2 0.0004
336 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
337 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
338 HAEMATOLOGICAL INFECTION 1 0.0004
339 DERMAL CYST 1 0.0004
340 INJECTION SITE EXTRAVASATION 5 0.0004
341 GASTROINTESTINAL TUBE INSERTION 1 0.0004
342 INJECTION SITE DISCOLOURATION 5 0.0004
343 OVARIAN CYST 4 0.0004
344 DERMATOMYOSITIS 1 0.0004
345 DIABETIC COMPLICATION 1 0.0004
346 INSURANCE ISSUE 6 0.0004
347 AMMONIA INCREASED 2 0.0004
348 SEDATION COMPLICATION 1 0.0004
349 LACTOSE INTOLERANCE 1 0.0004
350 ENDOCARDITIS 2 0.0004
351 ABNORMAL UTERINE BLEEDING 1 0.0004
352 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
353 LIPOMA 1 0.0004
354 INJECTION SITE INDURATION 5 0.0004
355 PRODUCT USE COMPLAINT 6 0.0004
356 RADICULOPATHY 1 0.0004
357 PROTEIN TOTAL INCREASED 1 0.0004
358 GASTROINTESTINAL INJURY 1 0.0004
359 BEHAVIOUR DISORDER 2 0.0004
360 PROTEINURIA 7 0.0004
361 NORMAL NEWBORN 2 0.0004
362 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
363 IMPAIRED GASTRIC EMPTYING 5 0.0004
364 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
365 PROCTITIS 1 0.0004
366 ENDOTRACHEAL INTUBATION 1 0.0004
367 SKIN HYPERTROPHY 1 0.0004
368 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
369 PANCREATIC CARCINOMA METASTATIC 1 0.0004
370 INJECTION SITE MASS 13 0.0004
371 INTENTIONAL DOSE OMISSION 10 0.0004
372 PRODUCT DOSE OMISSION ISSUE 102 0.0003
373 POST PROCEDURAL HAEMORRHAGE 4 0.0003
374 SPLENOMEGALY 4 0.0003
375 NECK INJURY 1 0.0003
376 CARDIAC PACEMAKER INSERTION 2 0.0003
377 WEIGHT DECREASED 93 0.0003
378 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
379 FIBROSIS 1 0.0003
380 PIGMENTATION DISORDER 2 0.0003
381 PRODUCT DOSE OMISSION 21 0.0003
382 NEPHROPATHY 3 0.0003
383 EYELIDS PRURITUS 1 0.0003
384 INJECTION SITE HYPERSENSITIVITY 1 0.0003
385 IRIDOCYCLITIS 1 0.0003
386 TRANSAMINASES INCREASED 7 0.0003
387 AUTOIMMUNE DISORDER 3 0.0003
388 HEPATIC NEOPLASM 1 0.0003
389 ASCITES 9 0.0003
390 POLYP 2 0.0003
391 LABORATORY TEST ABNORMAL 9 0.0003
392 INJECTION SITE INFECTION 1 0.0003
393 APPETITE DISORDER 2 0.0003
394 SKIN INJURY 1 0.0003
395 NEPHRITIS 1 0.0003
396 POSTOPERATIVE WOUND INFECTION 2 0.0003
397 HEPATIC CYST 1 0.0003
398 DIABETIC RETINOPATHY 1 0.0003
399 B-CELL LYMPHOMA 1 0.0003
400 COORDINATION ABNORMAL 4 0.0003
401 SYRINGE ISSUE 5 0.0003
402 AMENORRHOEA 5 0.0003
403 INJECTION SITE PRURITUS 19 0.0003
404 HAND FRACTURE 2 0.0003
405 THERMAL BURN 2 0.0003
406 SKIN LACERATION 3 0.0003
407 CAROTID ARTERY OCCLUSION 1 0.0003
408 GASTROENTERITIS 4 0.0003
409 INTENTIONAL UNDERDOSE 2 0.0003
410 FOOD INTOLERANCE 1 0.0003
411 FOOT DEFORMITY 3 0.0003
412 HYPOPHOSPHATAEMIA 2 0.0003
413 ARTHROPOD BITE 2 0.0003
414 MALNUTRITION 3 0.0003
415 PARANASAL SINUS DISCOMFORT 1 0.0003
416 SLEEP APNOEA SYNDROME 5 0.0003
417 ACIDOSIS 2 0.0003
418 ATRIOVENTRICULAR BLOCK 2 0.0003
419 HYPOALBUMINAEMIA 2 0.0003
420 RHINOVIRUS INFECTION 1 0.0003
421 PROCEDURAL HAEMORRHAGE 1 0.0003
422 NAIL DISCOLOURATION 1 0.0003
423 SKIN ODOUR ABNORMAL 1 0.0003
424 EXPOSURE VIA BREAST MILK 1 0.0003
425 LOCALISED INFECTION 6 0.0002
426 RHINITIS 2 0.0002
427 ENURESIS 1 0.0002
428 PRODUCT ADMINISTRATION ERROR 5 0.0002
429 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
430 INJECTION SITE URTICARIA 6 0.0002
431 HOSPITALISATION 37 0.0002
432 CONGESTIVE CARDIOMYOPATHY 1 0.0002
433 INJECTION SITE IRRITATION 3 0.0002
434 POOR PERIPHERAL CIRCULATION 1 0.0002
435 VITAMIN D DECREASED 2 0.0002
436 PRODUCT DISPENSING ISSUE 1 0.0002
437 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
438 WEIGHT INCREASED 52 0.0002
439 PYELONEPHRITIS 2 0.0002
440 OCULAR ICTERUS 1 0.0002
441 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
442 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
443 ONYCHOMYCOSIS 1 0.0002
444 TOOTH INFECTION 3 0.0002
445 HAEMORRHAGIC ANAEMIA 1 0.0002
446 CATHETERISATION CARDIAC 1 0.0002
447 ABORTION SPONTANEOUS 9 0.0002
448 HEAVY MENSTRUAL BLEEDING 2 0.0002
449 PRODUCT AVAILABILITY ISSUE 5 0.0002
450 ABDOMINAL HERNIA 1 0.0002
451 INJECTION SITE PAPULE 1 0.0002
452 EAR DISORDER 1 0.0002
453 IMMUNE THROMBOCYTOPENIA 1 0.0002
454 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
455 EYE OPERATION 1 0.0002
456 NERVE COMPRESSION 2 0.0002
457 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
458 NEPHROGENIC ANAEMIA 1 0.0002
459 FLANK PAIN 2 0.0002
460 SPINAL COLUMN STENOSIS 1 0.0002
461 VIRAL INFECTION 7 0.0002
462 GESTATIONAL DIABETES 1 0.0002
463 ACUTE RESPIRATORY FAILURE 4 0.0002
464 HYPERCHOLESTEROLAEMIA 2 0.0002
465 EAR PAIN 4 0.0002
466 INCORRECT DOSAGE ADMINISTERED 1 0.0002
467 NASAL POLYPS 1 0.0002
468 DECREASED APPETITE 47 0.0002
469 RENAL IMPAIRMENT 17 0.0002
470 FOOT OPERATION 1 0.0002
471 ABDOMINAL TENDERNESS 1 0.0002
472 PROTEIN URINE PRESENT 1 0.0002
473 HEPATIC ENZYME ABNORMAL 1 0.0002
474 INJECTION SITE HAEMORRHAGE 16 0.0002
475 HYPERAMMONAEMIA 1 0.0002
476 PREGNANCY 4 0.0002
477 CORONARY ARTERY STENOSIS 1 0.0002
478 DYSPHORIA 1 0.0002
479 DYSLIPIDAEMIA 1 0.0002
480 TOOTH ABSCESS 2 0.0002
481 INITIAL INSOMNIA 2 0.0002
482 INJECTION SITE WARMTH 4 0.0002
483 CACHEXIA 1 0.0002
484 PERIPHERAL VASCULAR DISORDER 1 0.0002
485 BLOOD CHOLESTEROL INCREASED 9 0.0002
486 FAILURE TO THRIVE 1 0.0002
487 BASAL CELL CARCINOMA 3 0.0002
488 TENDERNESS 2 0.0002
489 UNINTENDED PREGNANCY 2 0.0002
490 INJECTION SITE DISCOMFORT 2 0.0002
491 PREMATURE DELIVERY 3 0.0002
492 BRUXISM 1 0.0002
493 LACTIC ACIDOSIS 6 0.0002
494 PHARYNGITIS STREPTOCOCCAL 2 0.0002
495 JAW DISORDER 1 0.0002
496 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
497 HYPERKERATOSIS 1 0.0002
498 NERVE INJURY 2 0.0002
499 STREPTOCOCCAL INFECTION 1 0.0002
500 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
501 PREMATURE LABOUR 1 0.0002
502 INJECTION SITE BRUISING 14 0.0002
503 CHOLECYSTECTOMY 2 0.0002
504 CARDIAC VALVE DISEASE 1 0.0002
505 INJECTION SITE REACTION 12 0.0002
506 HYPOVOLAEMIA 1 0.0002
507 INJECTION SITE SWELLING 13 0.0002
508 PROTHROMBIN TIME PROLONGED 1 0.0002
509 BLOOD POTASSIUM DECREASED 5 0.0002
510 INGUINAL HERNIA 1 0.0002
511 INJECTION SITE RASH 5 0.0002
512 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
513 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
514 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
515 CELLULITIS 8 0.0002
516 FOOT FRACTURE 3 0.0002
517 ABDOMINAL PAIN LOWER 4 0.0002
518 PRODUCT COMPLAINT 4 0.0002
519 INJECTION SITE PAIN 48 0.0002
520 ENTERITIS 1 0.0002
521 ROTATOR CUFF SYNDROME 2 0.0002
522 PROCTALGIA 1 0.0002
523 RESPIRATORY TRACT INFECTION 4 0.0002
524 INJECTION SITE ERYTHEMA 19 0.0002
525 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
526 KIDNEY INFECTION 3 0.0002
527 SINUS DISORDER 3 0.0002
528 SARS-COV-2 TEST POSITIVE 2 0.0002
529 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
530 ABDOMINAL PAIN 35 0.0002
531 CARDIAC FAILURE ACUTE 1 0.0001
532 MENSTRUATION IRREGULAR 4 0.0001
533 PRODUCT PHYSICAL ISSUE 3 0.0001
534 INTENTIONAL PRODUCT MISUSE 13 0.0001
535 THERAPEUTIC RESPONSE DECREASED 9 0.0001
536 BRONCHIECTASIS 1 0.0001
537 FEEDING DISORDER 3 0.0001
538 ENCEPHALITIS 1 0.0001
539 LARGE INTESTINE POLYP 1 0.0001
540 MENTAL STATUS CHANGES 4 0.0001
541 INFLUENZA 16 0.0001
542 BLOOD TEST ABNORMAL 2 0.0001
543 OSTEOARTHRITIS 6 0.0001
544 SEASONAL ALLERGY 2 0.0001
545 IRRITABLE BOWEL SYNDROME 3 0.0001
546 HYPERSOMNIA 4 0.0001
547 CARDIOGENIC SHOCK 2 0.0001
548 CARDIAC DISORDER 13 0.0001
549 PARAESTHESIA ORAL 2 0.0001
550 FAECES SOFT 1 0.0001
551 RASH PUSTULAR 1 0.0001
552 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
553 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
554 ILLNESS 14 0.0001
555 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
556 COLON CANCER 2 0.0001
557 HEPATIC FUNCTION ABNORMAL 5 0.0001
558 KETOACIDOSIS 1 0.0001
559 HYDRONEPHROSIS 1 0.0001
560 ABDOMINAL PAIN UPPER 27 0.0001
561 NEPHROLITHIASIS 6 0.0001
562 BOWEL MOVEMENT IRREGULARITY 1 0.0001
563 DRUG EFFECT DECREASED 7 0.0001
564 DEVICE RELATED INFECTION 2 0.0001
565 FOOD ALLERGY 1 0.0001
566 MUSCULOSKELETAL CHEST PAIN 2 0.0001
567 ANKLE FRACTURE 2 0.0001
568 EXPOSURE DURING PREGNANCY 8 0.0001
569 EJECTION FRACTION DECREASED 2 0.0001
570 MENINGIOMA 2 0.0001
571 HAEMORRHAGIC STROKE 1 0.0001
572 GASTROINTESTINAL INFLAMMATION 1 0.0001
573 AFFECTIVE DISORDER 1 0.0001
574 FURUNCLE 1 0.0001
575 ULCER 2 0.0001
576 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
577 COVID-19 22 0.0001
578 ABDOMINAL DISTENSION 13 0.0001
579 STENT PLACEMENT 1 0.0001
580 BACK DISORDER 2 0.0001
581 DECUBITUS ULCER 1 0.0001
582 IMPAIRED HEALING 4 0.0001
583 BRONCHITIS 9 0.0001
584 VENTRICULAR TACHYCARDIA 2 0.0001
585 MENSTRUAL DISORDER 1 0.0001
586 EXPIRED PRODUCT ADMINISTERED 4 0.0001
587 PNEUMONIA ASPIRATION 3 0.0001
588 FUNGAL INFECTION 4 0.0001
589 TYPE 2 DIABETES MELLITUS 4 0.0001
590 HEPATITIS 3 0.0001
591 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
592 SKIN HYPERPIGMENTATION 1 0.0001
593 ANURIA 1 0.0001
594 BLOOD MAGNESIUM DECREASED 1 0.0001
595 CONDITION AGGRAVATED 35 0.0001
596 HYPERKALAEMIA 4 0.0001
597 BLOOD CALCIUM INCREASED 1 0.0001
598 LYMPHADENOPATHY 4 0.0001
599 LIVER DISORDER 5 0.0001
600 EAR INFECTION 3 0.0001
601 PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0001
602 MYOSITIS 1 0.0001
603 ANAL INCONTINENCE 1 0.0001
604 GASTROENTERITIS VIRAL 2 0.0001
605 LEUKOCYTOSIS 2 0.0001
606 BRAIN NEOPLASM 1 0.0001
607 SKIN DISCOLOURATION 5 0.0001
608 INCREASED TENDENCY TO BRUISE 1 0.0001
609 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
610 DYSURIA 4 0.0001
611 OVARIAN CANCER 1 0.0001
612 DIVERTICULITIS 3 0.0001
613 CONJUNCTIVITIS 2 0.0001
614 THINKING ABNORMAL 2 0.0001
615 SQUAMOUS CELL CARCINOMA 1 0.0001
616 INTESTINAL OBSTRUCTION 4 0.0001
617 BLOOD SODIUM DECREASED 2 0.0001
618 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
619 BLOOD URINE PRESENT 2 0.0001
620 POST PROCEDURAL COMPLICATION 2 0.0001
621 PRESCRIBED OVERDOSE 2 0.0001
622 DIZZINESS POSTURAL 1 0.0001
623 HYPOTONIA 1 0.0001
624 BRAIN INJURY 1 0.0001
625 PERITONITIS BACTERIAL 1 0.0001
626 CORONARY ARTERY DISEASE 3 0.0001
627 TASTE DISORDER 2 0.0001
628 MOTOR DYSFUNCTION 1 0.0001
629 SLUGGISHNESS 1 0.0001
630 EAR DISCOMFORT 1 0.0001
631 HELICOBACTER INFECTION 1 0.0001
632 INFECTION 14 0.0001
633 PERITONITIS 2 0.0001
634 ROAD TRAFFIC ACCIDENT 4 0.0001
635 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
636 SCRATCH 1 0.0001
637 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
638 MIGRAINE 9 0.0001
639 HYPOTHYROIDISM 3 0.0001
640 BREAST PAIN 1 0.0001
641 DECREASED ACTIVITY 1 0.0001
642 NASOPHARYNGITIS 17 0.0001
643 BACK INJURY 1 0.0001
644 SEPTIC SHOCK 4 0.0001
645 MENTAL DISORDER 4 0.0001
646 PRODUCT PRESCRIBING ISSUE 2 0.0001
647 ACUTE KIDNEY INJURY 14 0.0001
648 PRODUCT STORAGE ERROR 8 0.0001
649 GASTROINTESTINAL PAIN 1 0.0001
650 INJECTION SITE NODULE 1 0.0001
651 DEHYDRATION 12 0.0001
652 RASH MACULO-PAPULAR 2 0.0001
653 HYPERTENSIVE CRISIS 1 0.0001
654 SEPSIS 10 0.0001
655 NECK PAIN 5 0.0001
656 RASH PAPULAR 2 0.0001
657 SNEEZING 2 0.0001
658 HEART RATE IRREGULAR 2 0.0001
659 MITRAL VALVE INCOMPETENCE 1 0.0001
660 HEPATIC ENZYME INCREASED 6 0.0001
661 SINUSITIS 9 0.0001
662 DERMATITIS CONTACT 1 0.0001
663 HAEMATURIA 3 0.0001
664 MICTURITION URGENCY 1 0.0001
665 HYPOKALAEMIA 4 0.0001
666 METASTASES TO LUNG 1 0.0001
667 ELECTROLYTE IMBALANCE 1 0.0001
668 EYELID OEDEMA 1 0.0001
669 CAESAREAN SECTION 1 0.0001
670 HYPOXIA 3 0.0001
671 BLOOD IRON DECREASED 1 0.0001
672 PRODUCT PRESCRIBING ERROR 2 0.0001
673 ACCIDENT 1 0.0001
674 HYPERLIPIDAEMIA 1 0.0001
675 RASH ERYTHEMATOUS 4 0.0001
676 BURSITIS 1 0.0001
677 ADRENAL INSUFFICIENCY 1 0.0001
678 HYPERCALCAEMIA 1 0.0001
679 ABNORMAL WEIGHT GAIN 1 0.0001
680 VOMITING 38 0.0001
681 GENERALISED OEDEMA 1 0.0001
682 PHARYNGITIS 1 0.0001
683 ILEUS 1 0.0001
684 COLITIS 3 0.0001
685 MUSCLE ATROPHY 1 0.0001
686 HAEMATEMESIS 2 0.0001
687 HYPOPHAGIA 2 0.0001
688 MYDRIASIS 1 0.0001
689 OFF LABEL USE 68 0.0001
690 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
691 SKIN ULCER 2 0.0001
692 HIATUS HERNIA 1 0.0001
693 NAUSEA 61 0.0001
694 BEDRIDDEN 1 0.0001
695 GASTRITIS 2 0.0001
696 DEPRESSED MOOD 4 0.0001
697 DYSMENORRHOEA 1 0.0001
698 EYE HAEMORRHAGE 1 0.0001
699 SINUS CONGESTION 1 0.0001
700 RASH PRURITIC 4 0.0001
701 INFLUENZA LIKE ILLNESS 6 0.0001
702 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
703 RESPIRATORY DISTRESS 2 0.0001
704 ANAPHYLACTIC REACTION 4 0.0001
705 FEELING COLD 2 0.0001
706 HYPOMAGNESAEMIA 1 0.0001
707 HAEMOPTYSIS 2 0.0001
708 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
709 FLATULENCE 4 0.0001
710 DIALYSIS 1 0.0001
711 SINUS TACHYCARDIA 1 0.0001
712 CHEST PAIN 13 0.0001
713 PARALYSIS 1 0.0001
714 ANGINA PECTORIS 2 0.0001
715 SOMNOLENCE 14 0.0001
716 ACCIDENTAL UNDERDOSE 1 0.0001
717 PANCREATIC CARCINOMA 2 0.0001
718 ANOSMIA 1 0.0001
719 INJECTION SITE HAEMATOMA 1 0.0001
720 ACUTE MYOCARDIAL INFARCTION 2 0.0001
721 PULMONARY MASS 1 0.0001
722 PULMONARY OEDEMA 3 0.0001
723 ANXIETY 19 0.0001
724 PREMATURE BABY 2 0.0001
725 HEPATIC FAILURE 2 0.0001
726 BLOOD COUNT ABNORMAL 1 0.0001
727 URTICARIA 11 0.0001
728 TINNITUS 3 0.0001
729 HIP ARTHROPLASTY 1 0.0001
730 FEELING HOT 4 0.0001
731 DRUG ADMINISTRATION ERROR 2 0.0001
732 EMOTIONAL DISORDER 2 0.0001
733 URINARY TRACT INFECTION 11 0.0001
734 PRODUCT USE ISSUE 12 0.0001
735 HEADACHE 40 0.0001
736 ARRHYTHMIA 3 0.0001
737 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
738 NEUROPATHY PERIPHERAL 6 0.0001
739 CYSTITIS 2 0.0001
740 MOOD SWINGS 2 0.0001
741 SCIATICA 1 0.0001
742 METABOLIC ACIDOSIS 2 0.0001
743 CARDIAC FAILURE 5 0.0001
744 CARDIAC FAILURE CONGESTIVE 5 0.0001
745 PNEUMONIA 20 0.0001
746 MUSCLE TIGHTNESS 1 0.0001
747 BLOOD POTASSIUM INCREASED 1 0.0001
748 MALAISE 27 0.0001
749 PYREXIA 21 0.0001
750 STAPHYLOCOCCAL INFECTION 2 0.0001
751 COUGH 17 0.0001
752 CARDIAC ARREST 5 0.0001
753 CYTOMEGALOVIRUS INFECTION 1 0.0001
754 LEUKOPENIA 3 0.0001
755 SYNCOPE 6 0.0001
756 AGGRESSION 3 0.0001
757 URINARY RETENTION 2 0.0001
758 DRY SKIN 8 0.0001
759 ABDOMINAL DISCOMFORT 10 0.0001
760 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
761 FLUID RETENTION 3 0.0001
762 METRORRHAGIA 1 0.0001
763 DRUG INEFFECTIVE 77 0.0001
764 SCAR 1 0.0001
765 GASTRIC DISORDER 2 0.0001
766 PARANOIA 1 0.0001
767 ANAEMIA 11 0.0001
768 ORTHOSTATIC HYPOTENSION 1 0.0001
769 LOCAL SWELLING 1 0.0001
770 MUSCULOSKELETAL PAIN 3 0.0001
771 DEPRESSION 13 0.0001
772 METASTASES TO LIVER 1 0.0001
773 COLD SWEAT 1 0.0001
774 SLEEP DISORDER 4 0.0001
775 HEAD DISCOMFORT 1 0.0001
776 TACHYCARDIA 5 0.0001
777 ISCHAEMIC STROKE 1 0.0001
778 GALLBLADDER DISORDER 1 0.0001
779 ALOPECIA 11 0.0001
780 MOBILITY DECREASED 4 0.0001
781 CONSTIPATION 12 0.0001
782 END STAGE RENAL DISEASE 1 0.0001
783 ADVERSE EVENT 5 0.0001
784 ASTHENIA 20 0.0001
785 PHOTOPHOBIA 1 0.0001
786 CEREBROVASCULAR ACCIDENT 9 0.0001
787 UNEVALUABLE EVENT 4 0.0001
788 CHRONIC KIDNEY DISEASE 4 0.0001
789 PULMONARY FIBROSIS 1 0.0001
790 LOWER LIMB FRACTURE 1 0.0001
791 SEIZURE 6 0.0001
792 GLAUCOMA 1 0.0001
793 ERUCTATION 1 0.0001
794 BACK PAIN 12 0.0001
795 CHOKING 1 0.0001
796 SURGERY 3 0.0001
797 NASAL CONGESTION 3 0.0001
798 MENORRHAGIA 1 0.0001
799 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
800 CATARACT 3 0.0001
801 FATIGUE 39 0.0001
802 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
803 NO ADVERSE EVENT 9 0.0000
804 FULL BLOOD COUNT DECREASED 1 0.0000
805 PLEURAL EFFUSION 3 0.0000
806 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
807 DISCOMFORT 3 0.0000
808 INJURY ASSOCIATED WITH DEVICE 1 0.0000
809 BLINDNESS 2 0.0000
810 PRODUCT PREPARATION ERROR 1 0.0000
811 OSTEOPOROSIS 2 0.0000
812 CARDIO-RESPIRATORY ARREST 2 0.0000
813 EATING DISORDER 1 0.0000
814 RETCHING 1 0.0000
815 JOINT INJURY 1 0.0000
816 RECTAL HAEMORRHAGE 2 0.0000
817 DIARRHOEA 30 0.0000
818 VAGINAL HAEMORRHAGE 2 0.0000
819 BLOOD CREATININE INCREASED 3 0.0000
820 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
821 PAIN 28 0.0000
822 DEVICE DIFFICULT TO USE 3 0.0000
823 GASTROINTESTINAL DISORDER 4 0.0000
824 DIZZINESS 22 0.0000
825 APPLICATION SITE PRURITUS 1 0.0000
826 MEMORY IMPAIRMENT 6 0.0000
827 PERICARDIAL EFFUSION 1 0.0000
828 OROPHARYNGEAL PAIN 4 0.0000
829 RENAL DISORDER 2 0.0000
830 BREAST CANCER 4 0.0000
831 DRUG DOSE OMISSION 7 0.0000
832 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
833 DYSPHAGIA 4 0.0000
834 COMA 2 0.0000
835 FEELING ABNORMAL 10 0.0000
836 BLOOD PRESSURE FLUCTUATION 1 0.0000
837 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
838 DRUG INTOLERANCE 4 0.0000
839 MENTAL IMPAIRMENT 1 0.0000
840 RESPIRATORY FAILURE 3 0.0000
841 PRESYNCOPE 1 0.0000
842 ARTHRALGIA 17 0.0000
843 LIVER INJURY 1 0.0000
844 PAIN IN EXTREMITY 12 0.0000
845 ENCEPHALOPATHY 1 0.0000
846 ABASIA 1 0.0000
847 VISUAL IMPAIRMENT 5 0.0000
848 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
849 AGEUSIA 1 0.0000
850 HOT FLUSH 3 0.0000
851 ACNE 3 0.0000
852 CARDIOVASCULAR DISORDER 1 0.0000
853 LOSS OF CONSCIOUSNESS 5 0.0000
854 DRUG RESISTANCE 1 0.0000
855 DYSPNOEA 22 0.0000
856 HYPERHIDROSIS 5 0.0000
857 RASH GENERALISED 1 0.0000
858 HAEMATOMA 1 0.0000
859 NERVOUSNESS 2 0.0000
860 DEAFNESS 1 0.0000
861 HYPERTENSION 8 0.0000
862 HYPERSENSITIVITY 7 0.0000
863 JAUNDICE 1 0.0000
864 BLOOD BILIRUBIN INCREASED 1 0.0000
865 FREQUENT BOWEL MOVEMENTS 1 0.0000
866 LIMB INJURY 1 0.0000
867 PALLOR 1 0.0000
868 PROCEDURAL PAIN 1 0.0000
869 ARTHROPATHY 2 0.0000
870 PANCYTOPENIA 2 0.0000
871 HYPONATRAEMIA 2 0.0000
872 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
873 RED BLOOD CELL COUNT DECREASED 1 0.0000
874 HYPOTENSION 7 0.0000
875 HERPES ZOSTER 2 0.0000
876 LETHARGY 2 0.0000
877 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
878 DYSSTASIA 1 0.0000
879 DYSPHONIA 2 0.0000
880 PALPITATIONS 4 0.0000
881 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
882 BLADDER CANCER 2 0.0000
883 DEATH 29 0.0000
884 RESPIRATORY DISORDER 1 0.0000
885 ADVERSE DRUG REACTION 3 0.0000
886 STOMATITIS 2 0.0000
887 OEDEMA PERIPHERAL 4 0.0000
888 VERTIGO 2 0.0000
889 EPILEPSY 1 0.0000
890 PERIPHERAL SWELLING 5 0.0000
891 LIMB DISCOMFORT 1 0.0000
892 FEMUR FRACTURE 1 0.0000
893 RASH 14 0.0000
894 NERVOUS SYSTEM DISORDER 1 0.0000
895 GAIT DISTURBANCE 6 0.0000
896 HIP FRACTURE 1 0.0000
897 NIGHT SWEATS 1 0.0000
898 RHINORRHOEA 2 0.0000
899 ATRIAL FIBRILLATION 3 0.0000
900 DEEP VEIN THROMBOSIS 2 0.0000
901 CHOLELITHIASIS 1 0.0000
902 DYSPEPSIA 3 0.0000
903 OSTEONECROSIS 1 0.0000
904 EYE DISORDER 1 0.0000
905 HEART RATE INCREASED 3 0.0000
906 RENAL FAILURE 4 0.0000
907 BLOOD PRESSURE DECREASED 2 0.0000
908 SKIN DISORDER 1 0.0000
909 MYALGIA 5 0.0000
910 HAEMOGLOBIN DECREASED 3 0.0000
911 DELIRIUM 1 0.0000
912 MYOCARDIAL INFARCTION 5 0.0000
913 DEVICE MALFUNCTION 2 0.0000
914 CEREBRAL HAEMORRHAGE 1 0.0000
915 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
916 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
917 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
918 CRYING 1 0.0000
919 C-REACTIVE PROTEIN INCREASED 1 0.0000
920 PANIC ATTACK 1 0.0000
921 ACCIDENTAL OVERDOSE 1 0.0000
922 AGITATION 2 0.0000
923 EYE SWELLING 1 0.0000
924 THROMBOCYTOPENIA 3 0.0000
925 EPISTAXIS 2 0.0000
926 HYPOAESTHESIA 4 0.0000
927 DYSARTHRIA 1 0.0000
928 DYSPNOEA EXERTIONAL 1 0.0000
929 INCORRECT DOSE ADMINISTERED 6 0.0000
930 INSOMNIA 7 0.0000
931 BLOOD PRESSURE INCREASED 4 0.0000
932 DISEASE PROGRESSION 3 0.0000
933 DISORIENTATION 1 0.0000
934 THROMBOSIS 2 0.0000
935 EXTRA DOSE ADMINISTERED 1 0.0000
936 DYSKINESIA 1 0.0000
937 RHABDOMYOLYSIS 1 0.0000
938 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
939 OVERDOSE 5 0.0000
940 ANGIOEDEMA 1 0.0000
941 SUICIDAL IDEATION 2 0.0000
942 SKIN IRRITATION 1 0.0000
943 MUSCLE SPASMS 4 0.0000
944 MULTIPLE SCLEROSIS 1 0.0000
945 CONTUSION 2 0.0000
946 DRY EYE 1 0.0000
947 ERYTHEMA 4 0.0000
948 INFLAMMATION 1 0.0000
949 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
950 HAEMORRHAGE 2 0.0000
951 ECZEMA 1 0.0000
952 SPEECH DISORDER 1 0.0000
953 PARAESTHESIA 3 0.0000
954 PRURITUS 7 0.0000
955 HAEMATOCHEZIA 1 0.0000
956 TREMOR 3 0.0000
957 BLISTER 1 0.0000
958 ASTHMA 2 0.0000
959 MUSCULAR WEAKNESS 2 0.0000
960 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
961 IRRITABILITY 1 0.0000
962 EMOTIONAL DISTRESS 2 0.0000
963 AMNESIA 1 0.0000
964 FEBRILE NEUTROPENIA 1 0.0000
965 FALL 5 0.0000
966 NEOPLASM MALIGNANT 1 0.0000
967 NEUTROPENIA 2 0.0000
968 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
969 VISION BLURRED 2 0.0000
970 BURNING SENSATION 1 0.0000
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
972 DYSGEUSIA 1 0.0000
973 HALLUCINATION 1 0.0000
974 DRUG DOSE OMISSION BY DEVICE 1 0.0000
975 DRUG DEPENDENCE 2 0.0000
976 CONFUSIONAL STATE 2 0.0000
977 DRY MOUTH 1 0.0000
978 BALANCE DISORDER 1 0.0000
979 MUSCULOSKELETAL STIFFNESS 1 0.0000
980 DEVICE ISSUE 1 0.0000
981 PULMONARY EMBOLISM 1 0.0000
982 CHEST DISCOMFORT 1 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
984 PLATELET COUNT DECREASED 1 0.0000
985 CHILLS 1 0.0000
986 JOINT SWELLING 1 0.0000
987 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
988 PSORIASIS 1 0.0000
989 PRODUCT QUALITY ISSUE 1 0.0000